Internal validation testing for new technologies: bringing telecytopathology into the mainstream.

Area of Science:

• Medical Technology
• Pathology
• Digital Health

Background:

• Implementing new laboratory technology faces regulatory compliance challenges.
• Telecytopathology offers potential for improved laboratory processes and patient care.
• Standardized procedures are needed for training, competency assessment, and validation of telecytopathology.

Purpose of the Study:

• To provide a detailed procedure for simultaneous user training, competency assessment, and internal validation of telecytopathology.
• To ensure compliance with regulatory requirements from the College of American Pathologists and CLIA '88.
• To validate telecytopathology for remote examination and diagnosis of cytology fine needle aspiration (FNA) specimens.

Main Methods:

• A blind correlation study involving six pathologists diagnosing 10 FNA cases via telecytopathology and direct microscopy.
• Pathologists first diagnosed specimens using telecytopathology, followed by direct microscopy after a 6-week interval.
• Diagnoses were compared to established final diagnoses and secondary reviews to assess interpathologist and intrapathologist reproducibility.

Main Results:

• An average concordance rate of 96.67% for interpathologist reproducibility was achieved.
• An average concordance rate of 95% for intrapathologist reproducibility was observed.
• All participating pathologists achieved a passing rate of 90% or better, demonstrating competency.

Conclusions:

• Telecytopathology is a validated and effective tool for remote diagnosis of cytology FNA specimens.
• The developed procedure ensures user competency and meets regulatory compliance requirements.
• This approach supports high-quality diagnostic testing and enhances patient care through technology implementation.